CD8A and neoplasm: Furthermore, consistent with mobilization and expansion of CD8+ T cells within the tumors, we found an increase in the frequency of splenic CD8+ T cells in tumor-bearing mice treated with intratumoral injections of ADU-S100 and 5AZADC.